Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management
Nutrients · 05.09.2024 · 16 (17) · 2996
DOI: 10.3390/nu16172996 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 05.09.2024. Verfasst von Seth Woodfin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Chemistry, School of Health Sciences, Liberty University, Lynchburg, VA 24515, USA. Hauptthemen laut MEDLINE: Multiple Sclerosis, Anti-Inflammatory Agents, Neuroprotective Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 377 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liberty University Office of Sponsored Programs and Research.
Abstract (Originalsprache)
Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by inflammation, demyelination, and neurodegeneration, resulting in significant disability and reduced quality of life. Current therapeutic strategies primarily target immune dysregulation, but limitations in efficacy and tolerability highlight the need for alternative treatments. Plant-derived compounds, including alkaloids, phenylpropanoids, and terpenoids, have demonstrated anti-inflammatory effects in both preclinical and clinical studies. By modulating immune responses and promoting neuroregeneration, these compounds offer potential as novel adjunctive therapies for MS. This review provides insights into the molecular and cellular basis of MS pathogenesis, emphasizing the role of inflammation in disease progression. It critically evaluates emerging evidence supporting the use of plant-derived compounds to attenuate inflammation and MS symptomology. In addition, we provide a comprehensive source of information detailing the known mechanisms of action and assessing the clinical potential of plant-derived compounds in the context of MS pathogenesis, with a focus on their anti-inflammatory and neuroprotective properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology and Chemistry, School of Health Sciences, Liberty University, Lynchburg, VA 24515, USA.
- Department of Biology, School of Sciences and Agriculture, Ferrum College, Ferrum, VA 24088, USA.
- Department of Human Nutrition, Foods and Exercise, College of Agriculture and Life Sciences, Virginia Tech, Blacksburg, VA 24061, USA.
- Department of Nutrition and Food Technology, Faculty of Agriculture, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan.
ORCID-Profile: Dane Fausnacht, William Moore, Hana Alkhalidy, Dongmin Liu
Förderung
- Liberty University Office of Sponsored Programs and Research
Zitieren
APA
Woodfin, S., Hall, S., Ramerth, A., Chapple, B., Fausnacht, D., Moore, W., Alkhalidy, H., & Liu, D. (2024). Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management. Nutrients, 16(17), 2996. https://doi.org/10.3390/nu16172996
Vancouver
Woodfin S, Hall S, Ramerth A, Chapple B, Fausnacht D, Moore W, et al. Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management. Nutrients. 2024;16(17):2996. doi:10.3390/nu16172996
BibTeX
@article{Woodfin2024,
author = {Woodfin, Seth and Hall, Sierra and Ramerth, Alexis and Chapple, Brooke and Fausnacht, Dane and Moore, William and Alkhalidy, Hana and Liu, Dongmin},
title = {Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {17},
pages = {2996},
doi = {10.3390/nu16172996}
}
EUVIMED